Therapy reports

Items 11-20 of 23

Set Ascending Direction
  1. Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2026
    Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2026
    May 2026
    $3,995.00

    Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026

    Learn More
Page
per page